Loading…
Reported covered position: U.S. Food & Drug Admin: Acting Assoc Commissioner, Legis Aff 8/20-2/22; Dep Dir, Ofc of Legislation 4/18-8/20 & 2/22-5/22; Sr Advisor, Ofc of Leg 1/17-4/18; Rep Brian Higgins: DC COS 4/07-1/17, Leg Coun 9/05-4/07
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
H.R. 2369: Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023; provisions related to diagnostic test regulation
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2026 · third_quarter · Q3
Section 301 Tariffs - Discussions related to the impact of Reciprocal Tariffs on U.S. biomanufacturing Section 232 Tariffs - Discussions related to the impact of Pharmaceutical Tariffs on U.S. biomanufacturing
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2026 · second_quarter · Q2
Source: Senate LDA
Section 301 Tariffs - Discussions related to the impact of Reciprocal Tariffs on U.S. biomanufacturing Section 232 Tariffs - Discussions related to the impact of Pharmaceutical Tariffs on U.S. biomanufacturing
General discussions related to federal procurement policy
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), U.S. Trade Representative (USTR)
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2026 · first_quarter · Q1
General discussions related to federal procurement policy
General discussions related to organoid modeling
Executive Order 14257: Regulating Imports With a Reciprocal Tariff to Rectify Trade Practices that Contribute to Large and Persistent Annual United States Goods Trade Deficits; provisions related to impact on manufacturers
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB)
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2025 · fourth_quarter · Q4
Executive Order 14257: Regulating Imports With a Reciprocal Tariff to Rectify Trade Practices that Contribute to Large and Persistent Annual United States Goods Trade Deficits; provisions related to impact on manufacturers Discussions related to Sectoral Tariffs and the impact on manufacturers
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2025 · third_quarter · Q3
Executive Order 14257: Regulating Imports With a Reciprocal Tariff to Rectify Trade Practices that Contribute to Large and Persistent Annual United States Goods Trade Deficits; provisions related to impact on manufacturers
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2025 · second_quarter · Q2
Executive Order 14257: Regulating Imports With a Reciprocal Tariff to Rectify Trade Practices that Contribute to Large and Persistent Annual United States Goods Trade Deficits; provisions related to impact on life science manufacturing
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2025 · first_quarter · Q1
Discussions related to Toxic Substance Control Act reform
Filing targets: SENATE
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2024 · fourth_quarter · Q4
Discussions related to biosafety testing Discussions related to pandemic preparedness programs with the National Security Commission on Emerging Biotechnology
General discussions related to tariffs and exports
General discussions related to industrial base expansion
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2024 · third_quarter · Q3
Discussions related to new site inspections Discussions related to pandemic preparedness programs
Filing targets: Health & Human Services, Dept of (HHS)
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2024 · second_quarter · Q2
Discussions related to the global supply of isotopes used in manufacturing
Discussions related to biomanufacturing consortia and support for industry
Filing targets: Energy, Dept of, Health & Human Services, Dept of (HHS)
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2024 · first_quarter · Q1
Discussions with the National Security Commission on Emerging Biotechnology regarding national security concerns related to biomanufacturers Discussions related to biomanufacturing consortia and support for industry
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2023 · fourth_quarter · Q4
Discussions related to industrial base expansion programs regarding biomanufacturing
Filing targets: Health & Human Services, Dept of (HHS)
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2023 · third_quarter · Q3
Discussions related to industrial base expansion programs regarding biomanufacturing Discussions related to industrial base expansion programs regarding biotechnology services
Discussions related to United States-Africa trade to support biomanufacturing capacity
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2023 · second_quarter · Q2
Discussions regarding appropriations related to biomanufacturing and Industrial Base Expansion Discussions related to deuterated water production
Discussions related to emerging technologies in drug manufacturing
Discussions related to the inclusion of biotechnology in prospective Executive Order to require federal screening of outbound investments
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2023 · first_quarter · Q1
Discussions related to the inclusion of biotechnology in potential rule to require federal screening of outbound investments
H.R. 2369: Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023; provisions related to diagnostic test regulation
Discussions related to support for the Industrial Base Expansion program for federal incentives to re-shore manufacturing for the U.S. medical supply chain
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2022 · fourth_quarter · Q4
Discussions related to concern about inclusion of biotechnology in potential rule to institute export controls or require screening of outbound investments
Discussions related to support for federal incentives to re-shore manufacturing for the U.S. medical supply chain
Discussions related to the Pandemic response effort and the use of public-private partnerships with the Health and Human Services' Assistant Secretary for Preparedness and Responses' (ASPR) and the Biomedical Advanced Research and Development Authority (BARDA)
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2022 · third_quarter · Q3
Discussions related to the Health and Human Services' Assistant Secretary for Preparedness and Responses' (ASPR) Medical Countermeasures Program, expressing support for the industrial base expansion program and educating officials on the public benefit of a candidate for the program.
General discussions related to access to foreign markets for Company products and services General discussions related to the impact due to the loss of intellectual property protections via a Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) Waiver on the medical supply chain General discussions related to amending export control policy to facilitate the export of products and services necessary for the manufacture of health technologies
EMD MILLIPORE CORPORATION via EMD MILLIPORE CORPORATION
2022 · third_quarter · RR
Issues related to the manufacturing and development of life sciences tools.
Issues related to the manufacturing and development of life sciences tools.
Issues related to the manufacturing and development of life sciences tools.
Discussions related to cultured meat
Filing targets: Commerce, Dept of (DOC), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
Discussions related to Health and Human Services' Assistant Secretary for Preparedness and Responses' (ASPR) Pandemic Response and working with ASPR and the Biomedical Advanced Research and Development Authority (BARDA) to facilitate the production of Monkeypox vaccine
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Issues related to the manufacturing and development of life sciences tools.
Issues related to the manufacturing and development of life sciences tools.
Issues related to the manufacturing and development of life sciences tools.
Issues related to the manufacturing and development of life sciences tools.